American International Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-41,153
| Closed | -$461K | – | 3065 |
|
|
2017
Q3 | $461K | Buy |
41,153
+2,293
| +6% | +$25.3K | ﹤0.01% | 1810 |
|
|
2017
Q2 | $427K | Buy |
38,860
+8,003
| +26% | +$80.1K | ﹤0.01% | 1811 |
|
|
2017
Q1 | $302K | Sell |
30,857
-6,018
| -16% | -$60.1K | ﹤0.01% | 1924 |
|
|
2016
Q4 | $398K | Sell |
36,875
-362
| -1% | -$3.62K | ﹤0.01% | 1784 |
|
|
2016
Q3 | $382K | Sell |
37,237
-21
| -0.1% | -$229 | ﹤0.01% | 1773 |
|
|
2016
Q2 | $487K | Buy |
37,258
+8,207
| +28% | +$108K | ﹤0.01% | 1602 |
|
|
2016
Q1 | $320K | Hold |
29,051
| – | – | ﹤0.01% | 2364 |
|
|
2015
Q4 | $267K | Sell |
29,051
-51
| -0.2% | -$427 | ﹤0.01% | 2546 |
|
|
2015
Q3 | $202K | Buy |
29,102
+34
| +0.1% | +$291 | ﹤0.01% | 2826 |
|
|
2015
Q2 | $285K | Sell |
29,068
-3,311
| -10% | -$30.2K | ﹤0.01% | 2694 |
|
|
2015
Q1 | $287K | Hold |
32,379
| – | – | ﹤0.01% | 2643 |
|
|
2014
Q4 | $284K | Sell |
32,379
-1,282
| -4% | -$10.4K | ﹤0.01% | 2644 |
|
|
2014
Q3 | $232K | Sell |
33,661
-24
| -0.1% | -$144 | ﹤0.01% | 2825 |
|
|
2014
Q2 | $177K | Sell |
33,685
-3,087
| -8% | -$15K | ﹤0.01% | 3098 |
|
|
2014
Q1 | $167K | Buy |
36,772
+883
| +2% | +$4.26K | ﹤0.01% | 2991 |
|
|
2013
Q4 | $181K | Sell |
35,889
-360
| -1% | -$1.73K | ﹤0.01% | 2859 |
|
|
2013
Q3 | $184K | Sell |
36,249
-2,869
| -7% | -$16K | ﹤0.01% | 2813 |
|
|
2013
Q2 | $194K | Buy |
+39,118
| New | +$186K | ﹤0.01% | 2601 |
|
American International Group's SCLN Position: Q4 2017 in Review
American International Group sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 41,153 shares — an estimated $461K sold.
American International Group first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $487K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- American International Group reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- American International Group sold 41,153 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $461K.
- American International Group first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
- American International Group's Sciclone Pharmaceuticals Inc position peaked at $487K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on American International Group's 13F filing for Q4 2017, filed 9 Feb 2018.